Plus Pharma

Product NDC
51645-735
11-digit product format
516450735
Labeler code
51645
Product ID
51645-735_98d204ae-3e1a-bbb9-e053-2995a90afe40
Type
HUMAN OTC DRUG
Nonproprietary name
CALCIUM CARBONATE
Dosage form
TABLET, CHEWABLE
Route
ORAL
Labeler
Gemini Pharmaceuticals, Inc. dba Plus Pharma
Application
part331
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2006-03-27
Marketing end
2022-03-31
Substance
CALCIUM CARBONATE
Active strength
500 mg/1
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct51645-735DDiscontinued by firm2026-10-02
excluded packagepackage51645-73551645-735-15DDiscontinued by firm2026-10-02

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage51645-735-15d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage51645-735-15f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage51645-735-152ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage51645-735-15a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage51645-735-15cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage51645-735-15cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage51645-735-15302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage51645-735-15ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage51645-735-150efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage51645-735-15ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage51645-735-15367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage51645-735-15557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
bee4fa8d-8d82-423a-a0b5-40a89dd13a99Product name120250618
e0d2eb29-08bd-4bba-90d1-c91c68a38767Product name420250516
30b0ac6e-02aa-0e5c-0d8b-cffdf3a282b2Product name520250304
334fe8d2-68fb-4331-a576-420e302ec069Product name720240320
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
e92765c1-be81-432a-b909-1b10777ec378Product name120190208
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
0441a8f5-3835-497c-aedd-bc78cba56b2aProduct name120150317
87711080-88eb-65c5-b2dd-bf99e700a372Product name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
CALCIUM CARBONATEACTIVE INGREDIENTH0G9379FGKPLUS PHARMA CALCIUM ANTACID (CALCIUM CARBONATE) TABLET, CHEWABLE [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]1
CALCIUM CATIONACTIVE MOIETY2M83C4R6ZBPLUS PHARMA CALCIUM ANTACID (CALCIUM CARBONATE) TABLET, CHEWABLE [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]1
ACACIAINACTIVE INGREDIENT5C5403N26OPLUS PHARMA CALCIUM ANTACID (CALCIUM CARBONATE) TABLET, CHEWABLE [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UPLUS PHARMA CALCIUM ANTACID (CALCIUM CARBONATE) TABLET, CHEWABLE [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]1
D&C RED NO. 27INACTIVE INGREDIENT2LRS185U6KPLUS PHARMA CALCIUM ANTACID (CALCIUM CARBONATE) TABLET, CHEWABLE [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]1
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBDPLUS PHARMA CALCIUM ANTACID (CALCIUM CARBONATE) TABLET, CHEWABLE [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30PLUS PHARMA CALCIUM ANTACID (CALCIUM CARBONATE) TABLET, CHEWABLE [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]1
MALTODEXTRININACTIVE INGREDIENT7CVR7L4A2DPLUS PHARMA CALCIUM ANTACID (CALCIUM CARBONATE) TABLET, CHEWABLE [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]1
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4PLUS PHARMA CALCIUM ANTACID (CALCIUM CARBONATE) TABLET, CHEWABLE [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]1
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJPLUS PHARMA CALCIUM ANTACID (CALCIUM CARBONATE) TABLET, CHEWABLE [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]1
SUCROSEINACTIVE INGREDIENTC151H8M554PLUS PHARMA CALCIUM ANTACID (CALCIUM CARBONATE) TABLET, CHEWABLE [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]1

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
308907calcium carbonate 500 MG (Ca 200 MG) Chewable TabletPSN6133b620-5fa5-404c-a800-3b042f6f06423
308907calcium carbonate 500 MG Chewable TabletSCD6133b620-5fa5-404c-a800-3b042f6f06423
308907calcium carbonate 500 MG (equivalent to calcium 200 MG) Chewable TabletSY6133b620-5fa5-404c-a800-3b042f6f06423

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
51645-735-1551645073515150 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (51645-735-15) 2006-03-272022-03-31NoNoCurrent